Skip to main content

Table 2 Pathogenesis of disseminated intravascular coagulation in sepsis.

From: Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation

Mechanism Pathophysiology
1) Increased thrombin generation Mediated predominantlyby tissue factor/factor VIIa pathway
2) Impaired function of physiological anticoagulant pathway  
   a) Reduction of antithrombin levels The result of a combination of increased consumption, enzyme degradation, impaired liver synthesis and vascular leakage
   b) Depression of protein C system The result of a combination of increased consumption, impaired liver synthesis, vascular leakage and down- regulation of thrombomodulin
   c) Insufficienttissue factor pathway inhibitor (TFPI)  
3) Impaired fibrinolysis Mediated by release of plasminogen activators from endothelial cells immediately followed by an increase in the plasma levels of plasminogen activator inhibitor type 1 (PAI-1)
4) Activation of inflammatory pathway Mediated by activated coagulation proteins and by depression of the protein C system